Kalaris Therapeutics offers differentiated approach to neovascular AMD with its lead candidate TH103. Click here to read my ...
The FDA approved Nufymco as an interchangeable biosimilar to Lucentis, making it the second approved ranibizumab biosimilar ...
Panelists discuss how faricimab and aflibercept 8 mg compare in drying and durability and how clinicians manage IOP ...
A clinical trial is investigating whether a stem cell-derived patch can replace disease-damaged cells and restore vision. Age-related macular degeneration is a steadily worsening eye disease and the ...
X-linked retinoschisis gene replacement therapy, aiming to improve retinal architecture and visual function in young male ...
ABC13 Houston on MSN
Woman charged after injecting patient with counterfeit filler, practicing without license: Records
Documents state that Iris Garcia assured a patient of her medical certification, but later refused to provide any ...
I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness/fitness myths. In my free time I enjoy ...
Aflibercept 8 mg every 12 or 16 weeks provides visual and anatomic gains in patients with polypoidal choroidal vasculopathy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback